The importance of understanding amylin signaling mechanisms for therapeutic development in the treatment of Alzheimer's disease

S Servizi, RR Corrigan… - Current pharmaceutical …, 2020 - ingentaconnect.com
Type II Diabetes (T2D) is a major risk factor for Alzheimer's Disease (AD). These two
diseases share several pathological features, including amyloid accumulation, inflammation …
被引用次数：5 相关文章
[PDF] researchgate.net

[PDF][PDF] The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

S Servizi, RR Corrigan… - Current Pharmaceutical …, 2020 - researchgate.net
Type II Diabetes (T2D) is a major risk factor for Alzheimer's Disease (AD). These two
diseases share several pathological features, including amyloid accumulation, inflammation …

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease.

S Servizi, RR Corrigan, G Casadesus - Current Pharmaceutical …, 2020 - europepmc.org
Abstract Type II Diabetes (T2D) is a major risk factor for Alzheimer's Disease (AD). These
two diseases share several pathological features, including amyloid accumulation …
[HTML] nih.gov

[HTML][HTML] The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

S Servizi, RR Corrigan… - Current pharmaceutical …, 2020 - ncbi.nlm.nih.gov
Abstract Type II Diabetes (T2D) is a major risk factor for Alzheimer's Disease (AD). These
two diseases share several pathological features, including amyloid accumulation …

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

S Servizi, RR Corrigan… - Current pharmaceutical …, 2020 - pubmed.ncbi.nlm.nih.gov
Type II Diabetes (T2D) is a major risk factor for Alzheimer's Disease (AD). These two
diseases share several pathological features, including amyloid accumulation, inflammation …